Zydus Lifesciences Gains on Licensing, Supply Deal with Synthon BV
Mumbai, September 5 (Kiran News) — Shares of Zydus Lifesciences rose in Thursday’s session after its wholly owned subsidiary, Zydus Lifesciences Global FZE, signed an exclusive licensing and supply agreement with the Netherlands-based Synthon BV for the US market. At 11:00 am, the stock was trading at ₹1,036.70, up 2.44% from its previous close of … Read more
